Cas:72894-20-3 N-[5-[bis(2-prop-2-enoxyethyl)amino]-2-[(2-bromo-4,6-dinitrophenyl)diazenyl]-4-methoxyphenyl]acetamide manufacturer & supplier

Chemical Name:N-[5-[bis(2-prop-2-enoxyethyl)amino]-2-[(2-bromo-4,6-dinitrophenyl)diazenyl]-4-methoxyphenyl]acetamide

CAS.NO:72894-20-3

Synonyms:N-[5-[bis(2-prop-2-enoxyethyl)amino]-2-[(2-bromo-4,6-dinitrophenyl)diazenyl]-4-methoxyphenyl]acetamide

Molecular Formula:C₂₅H₂₉BrN₆O₈

Molecular Weight:621.43700

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:773.8ºC at 760 mmHg

Density:1.41g/cm3

Index of Refraction:1.594

PSA:179.88000

Exact Mass:620.12300

LogP:7.55540

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like N-[5-[bis(2-prop-2-enoxyethyl)amino]-2-[(2-bromo-4,6-dinitrophenyl)diazenyl]-4-methoxyphenyl]acetamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-[5-[bis(2-prop-2-enoxyethyl)amino]-2-[(2-bromo-4,6-dinitrophenyl)diazenyl]-4-methoxyphenyl]acetamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-[5-[bis(2-prop-2-enoxyethyl)amino]-2-[(2-bromo-4,6-dinitrophenyl)diazenyl]-4-methoxyphenyl]acetamide Use and application,N-[5-[bis(2-prop-2-enoxyethyl)amino]-2-[(2-bromo-4,6-dinitrophenyl)diazenyl]-4-methoxyphenyl]acetamide technical grade,usp/ep/jp grade.

Related News: Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application. N-[5-[bis(2-prop-2-enoxyethyl)amino]-2-[(2-bromo-4,6-dinitrophenyl)diazenyl]-4-methoxyphenyl]acetamide manufacturer In the current trial, a total of 196 patients were randomly chosen to receive either the vaccine or a placebo. N-[5-[bis(2-prop-2-enoxyethyl)amino]-2-[(2-bromo-4,6-dinitrophenyl)diazenyl]-4-methoxyphenyl]acetamide supplier This means that the drug attributes of the drug substance will be lost in the future, and the monopoly power of some drug substances will also be lost. The preparation company will become the main person in charge of the drug. The drug preparation company will be responsible for the quality of the original excipients. It will be more cautious, some raw and auxiliary materials companies whose quality cannot be guaranteed will be gradually eliminated, and the industry concentration will be further improved. N-[5-[bis(2-prop-2-enoxyethyl)amino]-2-[(2-bromo-4,6-dinitrophenyl)diazenyl]-4-methoxyphenyl]acetamide vendor The program caused the price of some drugs to plunge more than 90% when it was introduced last year in some cities, state news agency Xinhua said. N-[5-[bis(2-prop-2-enoxyethyl)amino]-2-[(2-bromo-4,6-dinitrophenyl)diazenyl]-4-methoxyphenyl]acetamide factory Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application.